These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 26232188)
1. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents. Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188 [TBL] [Abstract][Full Text] [Related]
2. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio. Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284 [TBL] [Abstract][Full Text] [Related]
3. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935 [TBL] [Abstract][Full Text] [Related]
4. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531 [TBL] [Abstract][Full Text] [Related]
5. UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress. Pons DG; Nadal-Serrano M; Torrens-Mas M; Valle A; Oliver J; Roca P Free Radic Biol Med; 2015 Sep; 86():67-77. PubMed ID: 25960046 [TBL] [Abstract][Full Text] [Related]
6. SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production. Torrens-Mas M; Pons DG; Sastre-Serra J; Oliver J; Roca P J Cell Biochem; 2017 Feb; 118(2):397-406. PubMed ID: 27420645 [TBL] [Abstract][Full Text] [Related]
7. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells. Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679 [TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
9. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line. Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J Int J Biochem Cell Biol; 2013 Jul; 45(7):1509-15. PubMed ID: 23618876 [TBL] [Abstract][Full Text] [Related]
10. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412 [TBL] [Abstract][Full Text] [Related]
11. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue. Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro. Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187 [TBL] [Abstract][Full Text] [Related]
13. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells. Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293 [TBL] [Abstract][Full Text] [Related]
14. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio. Sastre-Serra J; Nadal-Serrano M; Pons DG; Valle A; Oliver J; Roca P Cell Physiol Biochem; 2012; 29(1-2):261-8. PubMed ID: 22415095 [TBL] [Abstract][Full Text] [Related]
16. The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells. Pons DG; Vilanova-Llompart J; Gaya-Bover A; Alorda-Clara M; Oliver J; Roca P; Sastre-Serra J Int J Food Sci Nutr; 2019 Dec; 70(8):941-949. PubMed ID: 30945577 [TBL] [Abstract][Full Text] [Related]
17. 17-β estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-β. Giddabasappa A; Bauler M; Yepuru M; Chaum E; Dalton JT; Eswaraka J Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5278-87. PubMed ID: 20463317 [TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091 [TBL] [Abstract][Full Text] [Related]
19. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. Nadal-Serrano M; Sastre-Serra J; Pons DG; Miró AM; Oliver J; Roca P J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145 [TBL] [Abstract][Full Text] [Related]
20. ER alpha selective chromone, isoxazolylchromones, induces ROS-mediated cell death without autophagy. Kaushik S; Sanawar R; Lekshmi A; Chandrasekhar L; Nair M; Bhatnagar S; Santhoshkumar TR Chem Biol Drug Des; 2019 Jul; 94(1):1352-1367. PubMed ID: 31066219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]